S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82
S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82
S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82
S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82

InnovAge Stock Forecast, Price & News

+0.01 (+0.13%)
(As of 11/30/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
417,850 shs
Average Volume
381,499 shs
Market Capitalization
$1.08 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive INNV News and Ratings via Email

Sign-up to receive the latest news and ratings for InnovAge and its competitors with MarketBeat's FREE daily newsletter.

InnovAge logo

About InnovAge

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, dental, mental health and psychiatric, meals, and activities, as well as physical, occupational, and speech therapy; transportation to the PACE center and third-party medical appointments; and care management. It serves approximately 6,600 PACE participants in the United States of America; and operates seventeen PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.


See More Headlines

Industry, Sector and Symbol

Health services
Current Symbol
Previous Symbol
Year Founded

Sales & Book Value

Annual Sales
$637.80 million
Book Value
$2.64 per share


Pretax Margin




Free Float
Market Cap
$1.08 billion
Not Optionable

Company Calendar

Last Earnings
Fiscal Year End


Overall MarketRank

2.09 out of 5 stars

Analyst Opinion: 4.3Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

InnovAge (OTCMKTS:INNV) Frequently Asked Questions

Is InnovAge a buy right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for InnovAge in the last twelve months. There are currently 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" InnovAge stock.
View analyst ratings for InnovAge
or view top-rated stocks.

How has InnovAge's stock been impacted by Coronavirus?

InnovAge's stock was trading at $1.23 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, INNV shares have increased by 548.0% and is now trading at $7.97.
View which stocks have been most impacted by COVID-19

How were InnovAge's earnings last quarter?

InnovAge Holding Corp. (OTCMKTS:INNV) released its quarterly earnings results on Tuesday, November, 9th. The company reported $0.06 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.05 by $0.01.
View InnovAge's earnings history

What guidance has InnovAge issued on next quarter's earnings?

InnovAge updated its FY 2022 earnings guidance on Tuesday, November, 30th. The company provided EPS guidance of for the period. The company issued revenue guidance of $712 million-$725 million, compared to the consensus revenue estimate of $719.51 million.

What price target have analysts set for INNV?

7 brokers have issued 1-year target prices for InnovAge's stock. Their forecasts range from $8.00 to $28.00. On average, they expect InnovAge's stock price to reach $18.83 in the next year. This suggests a possible upside of 136.3% from the stock's current price.
View analysts' price targets for InnovAge
or view top-rated stocks among Wall Street analysts.

Who are InnovAge's key executives?

InnovAge's management team includes the following people:
  • Ms. Maureen Hewitt, Pres, CEO & Director (Age 60, Pay $1.63M)
  • Ms. Barbara K. Gutierrez, Chief Financial Officer (Age 58, Pay $695.77k)
  • Ms. Gina DeBlassie, Chief Operations Officer of Central Region
  • Mr. Edward Moore Kennedy Jr., Independent Director (Age 60, Pay $100k)
  • Hon. Marilyn Barbour Tavenner R.N., Independent Director (Age 70, Pay $100k)
  • Ms. Maria Lozzano, Corp. Chief Operating Officer (Age 41)
  • Ms. Alice Raia, Chief Information Officer
  • Ms. Vanessa D. Walton, Chief Legal Officer & Sec.
  • Ms. Robin Doerr, Chief Sales & Marketing Officer (Age 57)
  • Dr. Melissa Welch M.D., Chief Medical Officer (Age 60)

What other stocks do shareholders of InnovAge own?

What is InnovAge's stock symbol?

InnovAge trades on the OTCMKTS under the ticker symbol "INNV."

Who are InnovAge's major shareholders?

InnovAge's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (1.14%), TimesSquare Capital Management LLC (1.14%), Maverick Capital Ltd. (0.85%), William Blair Investment Management LLC (0.84%), Camber Capital Management LP (0.74%) and Bank of New York Mellon Corp (0.68%). Company insiders that own InnovAge stock include Edward Moore Jr Kennedy and Maureen Hewitt.
View institutional ownership trends for InnovAge

Which major investors are selling InnovAge stock?

INNV stock was sold by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Rock Springs Capital Management LP, Capital Research Global Investors, Camber Capital Management LP, Geode Capital Management LLC, TimesSquare Capital Management LLC, California State Teachers Retirement System, and Alliancebernstein L.P..
View insider buying and selling activity for InnovAge
or view top insider-selling stocks.

Which major investors are buying InnovAge stock?

INNV stock was bought by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Morgan Stanley, Maverick Capital Ltd., Millennium Management LLC, Renaissance Technologies LLC, Citadel Advisors LLC, Tudor Investment Corp Et Al, and Cambiar Investors LLC. Company insiders that have bought InnovAge stock in the last two years include Edward Moore Jr Kennedy, and Maureen Hewitt.
View insider buying and selling activity for InnovAge
or or view top insider-buying stocks.

How do I buy shares of InnovAge?

Shares of INNV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is InnovAge's stock price today?

One share of INNV stock can currently be purchased for approximately $7.97.

How much money does InnovAge make?

InnovAge has a market capitalization of $1.08 billion and generates $637.80 million in revenue each year.

How many employees does InnovAge have?

InnovAge employs 1,800 workers across the globe.

What is InnovAge's official website?

The official website for InnovAge is www.innovuspharma.com.

Where are InnovAge's headquarters?

InnovAge is headquartered at 8845 Rehco Road, San Diego CA, 92121.

How can I contact InnovAge?

InnovAge's mailing address is 8845 Rehco Road, San Diego CA, 92121. The company can be reached via phone at 844-803-8745 or via email at [email protected].

This page was last updated on 12/1/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.